Goal-Directed Fluid Therapy in Patients Undergoing Lower Limb Surgeries

November 10, 2023 updated by: Mahmoud Aboubakr Abdelkader, Zagazig University

Effects of Goal-Directed Fluid Therapy Guided by Inferior Vena Cava Collapsibility Index on Hemodynamics and Enhanced Recovery in Patients Undergoing Lower Limb Surgeries

Controlling the amount of fluids given to patients in perioperative setting can significantly influence their outcomes.

Study Overview

Detailed Description

To overcome these problems and avoid the complications of over or underhydration, we use the Goal-directed fluid therapy(GDFT) guided by Inferior vena cava(IVC) collapsibility index approach in which dynamic parameters of volume responsiveness as a guide for fluid therapy. This will ensure that the fluids given were deficient from the circulation and improve the recovery of the patients according to enhanced recovery after surgery(ERAS) protocols.

Study Type

Interventional

Enrollment (Estimated)

52

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Patient's acceptance.
  • Patients planned for elective lower limb surgery under spinal anesthesia.
  • Both sexes
  • Body Mass Index(BMI): <35
  • Age: 21 ~ 65 years
  • American Society of Anesthesiologists(ASA) Physical Status Classification System: Class I & II
  • Duration of surgery 2~3 hours

Exclusion Criteria:

  • Advanced kidney, liver, respiratory or cardiovascular disease.
  • Contraindication for spinal anesthesia.
  • Patients shifted to general anesthesia for any reason.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: GD Group
Patients will take oral clear fluids with carbohydrates content 2 hours preoperatively and intraoperative fluid intake will be guided by Inferior vena cava(IVC) diameter.
Measuring Inferior vena cava(IVC) diameter using ultrasound then calculation Inferior vena cava(IVC) collapsibility index and administer fluid accordingly.
Active Comparator: C Group
the standard fluid management group patients will be fasting 6 hours preoperatively and will receive intraoperative fluid in standard manner.
standard fluid management

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean Arterial Blood Pressure
Time Frame: intraoperatively every 5 minutes
intraoperative mean arterial blood pressure measured in mmHg
intraoperatively every 5 minutes
Quality of Recovery-40 score(QoR-40)
Time Frame: 24 hours postoperative
QoR-40 score ranges from 40 to 200, the higher the score the better the outcome
24 hours postoperative
Heart Rate
Time Frame: intraoperatively every 5 minutes
intraoperative heart rate will be continuously monitored and recorded every 5 minutes
intraoperatively every 5 minutes
Post Anesthesia Care Unit(PACU) Stay
Time Frame: 2 hours postoperatively
time spent in PACU after surgery measured in minutes
2 hours postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total fluid intake during operation
Time Frame: intraoperatively
Total fluid intake during operation
intraoperatively
Number of patients that needed Ephedrine or Atropine
Time Frame: intraoperatively
Number of patients that needed Ephedrine or Atropine intraoperatively
intraoperatively
Peripheral perfusion index
Time Frame: Intraoperatively
Peripheral Perfusion Index (PPI) is defined as "the ratio of pulsatile blood flow to the non-pulsatile blood flow". It ranges from 0.02% to 20% and it is measured using specific types pulse oximetry and it reflects the perfusion status of the body.
Intraoperatively
Length of hospital stay
Time Frame: the patient will be followed up for 60 days from day of surgery
the number of days from day of surgery until patient's discharge from hospital
the patient will be followed up for 60 days from day of surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mahmoud Abdelkader, MBBCh, Anesthesia, Intensive Care and Pain Management department, Faculty of Medicine, Zagazig University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 1, 2023

Primary Completion (Estimated)

July 1, 2024

Study Completion (Estimated)

August 1, 2024

Study Registration Dates

First Submitted

October 31, 2023

First Submitted That Met QC Criteria

November 10, 2023

First Posted (Actual)

November 15, 2023

Study Record Updates

Last Update Posted (Actual)

November 15, 2023

Last Update Submitted That Met QC Criteria

November 10, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 11122

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anesthesia

Clinical Trials on Goal-Directed Fluid Therapy guided by Inferior Vena Cava Collapsibility Index

Subscribe